Trial
NCT05101798
The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
NX Development Corp
Condition
Neoplasm
Intervention
5-Aminolevulinic acid Hydrochloride
Why stopped
NX Development Corporation closed the trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-28